Last reviewed · How we verify

NCT07179393

Evaluating the Efficacy of a Ladies Gaelic Football-Specific Injury Prevention Programme

Completed NA Last updated 26 December 2025
What this trial tests

NA trial testing Ladies Gaelic Football-Specific Injury Prevention Programme in Injury in 197 participants. Completed in 3 October 2025.

Timeline
23 June 2025
Primary endpoint
3 October 2025
3 October 2025

Quick facts

Lead sponsorDublin City University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment197
Start date23 June 2025
Primary completion3 October 2025
Estimated completion3 October 2025
Sites1 location across Ireland

Drugs / interventions tested

Conditions studied

Sponsor

Dublin City University

Who can join

Eligibility, any sex, with Injury or Physical Performances. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this research is to evaluate the impact of an injury prevention programme on injury risk factors and performance outcomes in Ladies Gaelic Football players. This injury prevention programme was designed with input from Ladies Gaelic football stakeholders and experts and this study will determine if this programme reduces injury risk and improves physical performance over time. Participants will complete physical performance tests before and after the intervention, which consists of incorporating the injury prevention programme into regular team training sessions for 12 weeks. The study will also integrate a qualitative component to assess player's perceptions of the programme and their willingness to implement it.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Injury

Currently open trials in the same condition.

Other Dublin City University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07179393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing